Body fluid-derived stem cells - an untapped stem cell source in genitourinary regeneration

Area of Science:

• Stem cell biology
• Regenerative medicine
• Biomaterials

Background:

• Somatic stem cells are sourced from solid tissues like bone marrow and adipose tissue for applications in tissue repair and drug development.
• Recent discoveries have identified stem cells in various body fluids, termed body fluid-derived stem cells (BFSCs).
• BFSCs possess comparable stemness properties to tissue-derived stem cells, including differentiation potential and immunomodulatory effects.

Purpose of the Study:

• To review the characteristics and therapeutic potential of body fluid-derived stem cells (BFSCs).
• To highlight the advantages of BFSCs, such as easier accessibility and non-invasive isolation.
• To discuss the applications of BFSCs in preclinical models, particularly for genitourinary abnormalities.

Main Methods:

• Literature review of studies identifying and characterizing stem cells in body fluids.
• Analysis of stemness properties, including cell surface markers and multi-differentiation potential.
• Evaluation of preclinical data on BFSC efficacy in disease models, focusing on genitourinary applications.

Main Results:

• BFSCs exhibit stemness properties comparable to solid tissue-derived stem cells.
• BFSCs are more easily accessible via non-invasive methods, avoiding enzymatic tissue digestion.
• Preclinical models demonstrate BFSC versatility in repairing genitourinary abnormalities through differentiation and paracrine mechanisms.

Conclusions:

• BFSCs offer a promising alternative to tissue-derived stem cells due to their accessibility and therapeutic potential.
• BFSCs demonstrate significant potential in regenerative medicine, particularly for genitourinary conditions.
• Optimization of protocols is crucial for the safe and effective therapeutic translation of BFSC-based therapies.